Could stem cells beat standard care for arthritic knees?
NCT ID NCT07542808
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a single injection of StromaForte, made from donor bone marrow cells, against a standard hyaluronic acid injection for knee osteoarthritis. About 140 adults with knee arthritis will receive one treatment and be followed for 12 months. The main goal is to see if StromaForte provides better pain relief during activity at 6 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KNEE ARTHRITIS, OSTEOARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Burjeel Medical City
RECRUITINGAbu Dhabi, United Arab Emirates
Contact Phone: •••-•••-•••• Email: •••••@•••••